HM
ABUS icon

HealthCor Management’s Arbutus Biopharma ABUS Stock Holding History

HealthCor Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000,000
Closed -$6.88M – 40
2016
Q3 		$6.88M Sell
2,000,000
-258,300
-11% -$1.01M 0.42% 31
2016
Q2 		$7.86M Buy
2,258,300
+29,000
+1% +$123K 0.43% 38
2016
Q1 		$9.21M Buy
2,229,300
+40,100
+2% +$143K 0.52% 34
2015
Q4 		$9.74M Buy
2,189,200
+39,200
+2% +$215K 0.59% 32
2015
Q3 		$13.1M Buy
2,150,000
+425,000
+25% +$3.77M 0.74% 31
2015
Q2 		$20.5M Buy
1,725,000
+1,006,200
+140% +$15.3M 1.03% 31
2015
Q1 		$12.6M Buy
+718,800
New +$14.7M 0.6% 42

Other funds holding ABUS

QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

HealthCor Management's ABUS Position: Q4 2016 in Review

HealthCor Management sold out of Arbutus Biopharma (ABUS) in Q4 2016, closing a stake of 2,000,000 shares — an estimated $6.88M sold.

HealthCor Management first reported a position in ABUS in Q1 2015 and held it in 7 quarters. The position peaked at $20.5M in Q2 2015. 55 funds tracked by Wall St. Rank hold ABUS as of Q4 2016.

  • HealthCor Management reported no remaining Arbutus Biopharma position as of Q4 2016 after selling out during the quarter.
  • HealthCor Management sold 2,000,000 Arbutus Biopharma shares in Q4 2016, an estimated $6.88M.
  • HealthCor Management first reported a position in Arbutus Biopharma in Q1 2015 and held it in 7 quarters.
  • HealthCor Management's Arbutus Biopharma position peaked at $20.5M in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2016.

Based on HealthCor Management's 13F filing for Q4 2016, filed 14 Feb 2017.